Age and residual cholesterol efflux affect HDL cholesterol levels and coronary artery disease in ABCA1 heterozygotes

Journal of Clinical Investigation

Volumn 106, Issue 10, 2000, Pages 1263-1270

  Clee, Susanne M ^a   Kastelein, John J P ^b   Van Dam, Marjel ^b   Marcil, Michel ^c   Roomp, Kirsten ^d   Zwarts, Karin Y ^a   Collins, Jennifer A ^d   Roelants, Roosje ^b   Tamasawa, Naoki ^e   Stulc, Tomás ^f   Suda, Toshihiro ^e   Ceska, Richard ^f   Boucher, Betsie ^c   Rondeau, Colette ^c   DeSouich, Christele ^a   Brooks Wilson, Angela ^d   Molhuizen, Henri O F ^b   Frohlich, Jiri ^g   Genest Jr , Jacques ^c   Hayden, Michael R ^a,h  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b ACADEMIC MEDICAL CENTER   (Netherlands)

^c ROYAL VICTORIA HOSPITAL   (Canada)

^d Xenon Genetics Inc   (Canada)

^e HIROSAKI UNIVERSITY   (Japan)

^f CHARLES UNIVERSITY   (Czech Republic)

^g ST PAUL S HOSPITAL   (Canada)

^h Centre for Molecular Medicine and Therapeutics   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL TRANSPORT; CONTROLLED STUDY; CORONARY ARTERY DISEASE; FEMALE; GENE MUTATION; HETEROZYGOTE; HUMAN; MAJOR CLINICAL STUDY; MALE; PHENOTYPE; PRIORITY JOURNAL; TANGIER DISEASE;

EID: 0033692757     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI10727     Document Type: Article

References (33)

1. High density lipoprotein cholesterol and mortality. The Framingham Heart Study
2. Isolated low HDL cholesterol as a risk factor for coronary heart disease mortality. A 21 year follow-up of 8000 men
3. 2 cholesterol in normolipidemic men with coronary artery disease
4. The metabolic role of lecithin: Cholesterol acyltransferase: Perspectives from pathology
5. Reverse cholesterol transport: A review of the process and its clinical implications
6. Molecular physiology of reverse cholesterol transport
7. Tangier disease. Combined clinical staff conference at the National Institutes of Health
8. The high density lipoprotein and apolipoprotein A-I-induced mobilization of cellular cholesterol is impaired in fibroblasts from Tangier disease subjects
9. Plasma and fibroblasts of Tangier disease patients are disturbed in transferring phospholipids onto apolipoprotein A-I
10. Mutations in ABC1 in Tangier disease and familial high-density lipoprotein deficiency
11. The gene encoding ATP-binding cassette transporter 1 is mutated in Tangier disease
12. Tangier disease is caused by mutations in the gene encoding ATP-binding cassette transporter 1
13. The Tangier disease gene product ABC1 controls the cellular apolipoprotein-mediated lipid removal pathway
14. Human ATP-binding cassette transporter 1 (ABC1): Genomic organization and identification of the genetic defect in the original Tangier disease kindred
15. Novel mutations in the gene encoding ATP-binding cassette 1 in four Tangier disease kindreds
16. An inventory of the human ABC proteins
17. Severe familial HDL deficiency in French-Canadian kindreds
18. Cellular cholesterol transport and efflux in fibroblasts are abnormal in subjects with familial HDL deficiency
19. Characterization of high density lipoproteins in patients heterozygous for Tangier disease
20. Tangier disease: Heterozygote detection and linkage analaysis
21. Abnormal concentrations and anomalous distribution of apolipoprotein A-I in Tangier disease
22. Coronary heart disease prevalence and other clinical features in familial high-density lipoprotein deficiency (Tangier disease)
23. Mutations in the ABC1 gene in familial HDL deficiency with defective cholesterol efflux
24. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, withour use of the preparative ultracentrifuge
25. The epidemiology of plasma high-density lipoprotein cholesterol levels. The Lipid Research Clinics Program Prevalence Study
26. Lipoprotein-cholesterol distributions in selected North American populations: The Lipid Research Clinics Program Prevalence Study
27. Cholesterol efflux regulatory protein, Tangier disease and familial high-density lipoprotein deficiency
28. ABCR unites what ophthalmologists divide(s)
29. Longitudinal and secular trends in lipoprotein cholesterol measurements in a general population sample. The Framingham Offspring Study
30. High-density lipoprotein: Multipotent effects on cells of the vasculature
31. Cellular cholesterol efflux in heterozygotes for Tangier disease is markedly reduced and correlates with high density lipoprotein cholesterol concentration and particle size
32. P-glycoprotein expression and regulation. Age related changes and potential effects on drug therapy
33. Prebeta-1 HDL in plasma of normolipidemic individuals: Influences of plasma lipoproteins, age, and gender